Immune Modulation by Regulatory T Cells in Helicobacter pylori-Associated Diseases

E-ISSN： 2212-3873|12|1|71-85

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.12, Iss.1, 2012-03, pp. : 71-85

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Regulatory T Cells and Tolerogenic Dendritic Cells as Critical Immune Modulators in Atherogenesis

Current Pharmaceutical Design, Vol. 21, Iss. 9, 2015-03 ,pp. : 1107-1117

Bentham Science Publishers

Access to resources Recommend Favorite

Helicobacter Pylori Infection, Immune Response and Vaccination

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 1, Iss. 3, 2001-11 ,pp. : 199-208

Bentham Science Publishers

Access to resources Recommend Favorite

Modulation of Regulatory T Cells in Health and Disease: Role of Toll-Like Receptors

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 8, Iss. 2, 2009-06 ,pp. : 124-129

Bentham Science Publishers

Access to resources Recommend Favorite

Regulatory T cells for immunotherapy of autoimmune diseases: from the bench to the bedside

By Rutella Sergio Danese Silvio Leone Giuseppe

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 11, 2005-11 ,pp. : 1595-1616

Informa Healthcare

Access to resources Recommend Favorite

CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor

By Furuta Takahisa Sugimoto Mitsushige Shirai Naohito Ishizaki Takashi

Pharmacogenomics, Vol. 8, Iss. 9, 2007-09 ,pp. : 1199-1210

Future Medicine

Access to resources Recommend Favorite